Useful Articles

May 2, 2025

Author: Ishwari Patil

MR Linac: Transforming Radiation Oncology with Precision and Real-Time Imaging

When 65-year-old Barry Dolling from Surrey was diagnosed with prostate cancer, he became the first UK patient to undergo treatment on the MR-Linac, a breakthrough technology that combines real-time MRI imaging with precise radiotherapy for improved outcomes and fewer side effects. The outcome is unparalleled treatment precision and the possibility of improved outcomes with fewer side effects for patients.

In this article, we explain what MR-Linac technology is and how it works, the groundbreaking union of MRI imaging with a linear accelerator, and how real-time imaging during treatment is changing therapy. We will talk about the most significant benefits this technology has to offer to patients and oncologists, contrast MR Linac therapy with conventional radiation techniques, and look ahead to how MR Linac is revolutionising the future of cancer treatment.

Lastly, we address some frequently asked questions – from which type of cancer are eligible for MR- Linac Treatment, to availability of MR-Linac and complementarity with other treatments to complete a picture of this revolutionary radiation oncology equipment.

What is MR-Linac Technology (Magnetic Resonance Linear Accelerator)?

MR-Linac is an MRI-guided linear accelerator, essentially an MRI scanner connected with a device for radiation therapy into one single machine. This unification allows physicians to directly target and cure cancer, utilising real-time magnetic resonance imaging to guide the beam of radiation. In clinical application, an MR-Linac allows clinicians to “see what they treat” in real-time, a dream for years pursued in oncology.

It continuously images the tumour and surrounding organs throughout the delivery of radiation, enabling on-the-spot adjustments to ensure the radiation hits the cancer and reduces damage to healthy tissue as much as possible.

MRI guidance in an MR-Linac means real-time adjustability of treatment with enhanced soft tissue resolution, and more precise and effective delivery of radiation than before. That is, the MR-Linac combines the diagnostic accuracy of MRI with the therapeutic power of a linear accelerator, introducing radiotherapy to a new age of precision.

How MR-Linac Works?

Traditional radiotherapy is planned using scans taken days or weeks in advance, and delivered with the assumption that a tumour will be in the same place for each treatment. In reality, organs and tumours can shift between or even during sessions.

For example, a full bladder or a deep breath can nudge a tumour out of the radiation field. MR-Linac overcomes this limitation by providing continuous MRI imaging during radiation therapy. Radiotherapy using the MR-Linac is transforming outcomes for patients with difficult-to-treat tumours.

Each treatment session typically begins with a fresh MRI scan on the MR-Linac, allowing the care team to tailor the day’s plan to the patient’s exact anatomy in that moment. As radiation is delivered, the machine keeps taking MRI images in real time, monitoring the tumour’s position and shape. If the tumour has moved or changed, the system can adapt the radiation beam on the fly to maintain pinpoint accuracy.

This adaptive process means the treatment is always based on the current state of the tumour, rather than a static plan. The MR-Linac effectively “sees” the tumour throughout the session and can respond to any motion. For example, if a tumour shrinks over a course of therapy or shifts slightly each day, the radiation targeting can be adjusted accordingly.

In short, MR-Linac works by combining imaging and treatment into one seamless workflow: scan, plan, and treat occur almost simultaneously, ensuring the radiation beam is always hitting the right spot with minimal guesswork.

The Fusion of MRI and Linear Accelerator

Bringing MRI and radiotherapy together in one machine was no small engineering feat. MRI machines contain powerful magnets, and linear accelerators involve high-energy radiation – two systems that historically didn’t play well together due to magnetic interference. For decades, radiation oncologists “dreamed of the day when we could see what we treat in real time,” as one leading physicist put it. Achieving this required innovative design solutions.

Engineers had to prevent the MRIs magnetic field from disrupting the radiation beam and vice versa. One approach used in MR-Linac systems has been to redesign the MRI’s magnet configuration. For instance, splitting the magnetic field to create a gap through which the radiation beam can pass undistorted. Solutions like this allowed the two technologies to operate simultaneously without compromising image quality or beam accuracy.

The payoff for overcoming these challenges is huge. The MRI component provides unparalleled visualisation of soft tissues during treatment – far superior to the X-ray or CT images used in conventional radiotherapy. Tumours and organs that might be indistinguishable on a CT scan are vividly defined on MRI, giving clinicians a clear view of the cancer target and critical structures in real time. This means radiation can be shaped and directed with extreme precision, hitting the tumour and avoiding healthy tissues better than ever before.

In essence, the fusion of MRI and Linac technology lets doctors perform radiation treatment with the eyes of an MRI guiding their aim. What was once a blind process (delivering radiation based on pre-recorded images and educated guesswork) becomes a fully sighted procedure. The result: improved accuracy, confidence, and potentially outcomes, as the treatment team can literally watch the tumour and adapt their approach as needed throughout each session.

Real-Time Imaging During Treatment

One of the most groundbreaking aspects of MR-Linac is its ability to provide real-time imaging during radiation delivery. This is a game-changer for tumours that move with normal body processes like breathing or digestion. With a conventional radiotherapy machine, if a patient takes a breath and the tumour shifts, the radiation beam might still fire at the preset target area – possibly missing the tumour and hitting healthy tissue.

MR-Linac solves this problem by acting like a motion-tracking sniper: it continuously monitors the tumour’s position and only delivers radiation when the tumour is in the intended target zone. If the tumour moves out of alignment, the beam can pause automatically until the tumour moves back into position. In practice, the MR-Linac “locks on” to the tumour’s motion. It’s somewhat akin to having a GPS that updates the target coordinates every second, ensuring the radiation dose always stays on course.

For example, imagine treating a lung tumour that inevitably moves as the patient breathes. The MR-Linac’s live MRI might show the tumour drift a centimeter as the patient inhales – prompting the system to momentarily hold the radiation beam until the patient exhales and the tumour falls back into line. This kind of real-time gating was never before possible with such precision. It enhances treatment accuracy and safety, since radiation is delivered only when conditions are ideal.

According to experts, the ability to adjust radiation in real time is especially beneficial for cancers prone to motion (like those in the lung, prostate or abdomen) and helps reduce collateral damage to healthy tissues. Essentially, the tumour can run, but it can’t hide – the MR-Linac tracks its every oscillation. This gives both clinicians and patients greater confidence that the radiation is hitting the cancer and only the cancer, even if the target is a moving one.

Key Benefits for Patients and Oncologists Using MR-Linac Technology

MR-Linac technology isn’t just a flashy gadget, it brings concrete benefits to both the patients receiving treatment and the oncologists delivering it. By combining precision and adaptability, MR Linac will allow us to change the experience and effectiveness of radiotherapy in multiple ways. Below, we break down the key advantages for patients and for clinicians.

For Patients

Higher Treatment Precision – MR-Linac’s real-time MRI guidance allows radiation to be directed with pinpoint accuracy at the tumour, significantly reducing the risk of harming surrounding healthy tissues.
Fewer Side Effects – Because less healthy tissue is exposed to radiation, patients tend to experience fewer and milder side effects compared to conventional radiotherapy. In practical terms, this could mean less fatigue, less skin irritation, and fewer gastrointestinal upsets during and after treatment.
Real-Time tumour Tracking – The MR-Linac continuously tracks the tumour’s position during each session. If the tumour moves (due to breathing or other bodily motions), the system adapts instantly, adjusting the beam or pausing as needed to maintain accurate targeting. Patients can take comfort in knowing that even if they breathe or fidget slightly, the machine is “following” the tumour and keeping the radiation on target.
Personalised Treatment Plans – Doctors can modify the treatment plan in real time or day-to-day, based on how the tumour is responding and any changes in the patient’s anatomy. In effect, the radiotherapy is personalised to the patient’s current needs each session – if a tumour has shrunk, or swelling has gone down, the plan can be tweaked immediately rather than sticking to a one-size-fits-all blueprint.
Non-Invasive and Painless – Like standard external beam radiotherapy, MR-Linac treatment is non-invasive – there are no incisions or needles involved. Aside from the usual noise of the MRI and the need to keep still, there is no sensation during the actual radiation delivery. Sessions typically last a bit longer than regular radiotherapy, but the experience is similar, involving no discomfort.
Shorter Treatment Courses – With its greater precision, MR-Linac can safely deliver higher doses per session in some cases. This raises the possibility of completing effective treatments in fewer sessions overall. In fact, MRI-guided systems have been used to condense what would traditionally be six weeks of daily treatments into a much shorter course – sometimes just a week of sessions, or even a single high-dose treatment for certain tumours.

For Oncologists

Improved Decision-Making – Having real-time imaging data at hand during treatment gives oncologists the ability to make informed decisions on the spot. If, for example, a tumour is seen changing in size or position, they can adjust the treatment plan immediately (such as altering the radiation dose or plan for subsequent sessions). This dynamic decision-making can enhance treatment effectiveness and safety, as doctors are no longer “blind” between pre-scan and delivery.
Enhanced Visualisation of Soft Tissues – Oncologists can see the treatment area with far greater clarity thanks to MRI’s superior soft-tissue contrast. Tumour boundaries, organs at risk, and even subtle anatomical changes are more visible.This improved visualisation aids in accurate tumour delineation and confidence that the radiation beams are conforming exactly to the tumour’s shape. It’s like switching from a fuzzy black-and-white map to a high-definition GPS – the target is crystal clear.
Reduced Margins of Error – In conventional radiotherapy, doctors often have to include a margin of healthy tissue around the tumour in the radiation field, as a buffer against uncertainty in tumour position. With MR-Linac’s precise guidance, these margins can be tightened. The radiation can be confined more strictly to the tumour itself, since any movement or change can be caught in real time. This reduces the volume of healthy tissue receiving radiation, lowering the risk of side effects
Data-Rich Imaging for Research and Development – Every MR-Linac treatment generates a wealth of MRI data – essentially a live record of how the tumour and organs respond throughout therapy. This trove of information is incredibly valuable for research. Oncologists and scientists can study these images to better understand tumour behavior, evaluate responses early, and develop improved treatment protocols. The MR-Linac doubles as a research tool, providing insights that could drive the next generation of radiotherapy techniques and oncologic discoveries.
Adaptive Therapy Capabilities – The MR-Linac allows for true adaptive radiotherapy. Oncologists can reshape and re-optimise the treatment plan in real time, adjusting for changes in tumour size, shape, or position even during a treatment session. This on-the-fly adaptability means the treatment is always optimally tailored – if a tumour shrinks mid-course, the radiation field can shrink with it; if an organ shifts, the plan can re-adjust.

MR Linac Treatment vs. Traditional Radiation Therapy Systems

The fundamental difference lies in the imaging. Traditional radiation therapy (using standard linac machines) is typically guided by CT scans or X rays taken before treatment. Once the patient is on the table, the machine delivers radiation according to a pre-set plan, with only minor adjustments using surface markers or brief X-ray checks. If the tumour moves or the patient’s internal anatomy shifts during treatment, conventional systems have limited ability to respond in that instant. This can lead to healthy tissue inadvertently receiving radiation, or the tumour not getting the full intended dose.

For example, organs in the chest and abdomen constantly move as we breathe; a traditional radiotherapy machine cannot account for this motion in real time, so some radiation may miss the mark. Similarly, if a tumour shrinks over a multi-week course of treatment, a conventional plan might end up targeting an area slightly larger than necessary toward the end, exposing adjacent tissue unnecessarily.

MR Linac transforms this scenario by introducing adaptive, real-time guidance. It’s the difference between treating a “moving target” blindly versus tracking it with a live camera. Because MR-Linac can see the tumour during treatment, it ensures the radiation beam remains locked onto it, even if the tumour changes shape or position.

Studies have noted that the high image quality and adaptability of MR-Linac make it possible to deliver high radiation doses to tumours while minimising damage to surrounding healthy tissue, even for tumours that move or deform during therapy. Traditional systems compensate for motion by widening the target area (and thus hitting more normal tissue); MR-Linac instead compensates by dynamically adjusting the beam, keeping the target area tight.

The Future of Radiation Therapy with MR Linac Innovation

The emergence of MR Linac is just the beginning of a new chapter in cancer treatment. Looking ahead, we can expect this technology to become more refined and widely accessible. Early MR-Linac machines are large and complex, found only in cutting-edge centres, but as with any technology, advancements in engineering are likely to make future systems more compact and cost-effective.

This could pave the way for more hospitals to install MR-Linacs, bringing MRI-guided radiotherapy to a broader population of patients. In fact, only a handful of these machines were in use worldwide when they first gained approval in 2018, but that number is steadily growing as the benefits become evident and costs gradually come down.

Another exciting frontier is the integration of artificial intelligence (AI) and advanced automation with MR-Linac therapy. AI algorithms are already being developed to assist in treatment planning and image analysis for radiotherapy. In the context of MR-Linac, AI could help interpret the continuous stream of MRI data in real time – automatically contouring tumours, predicting movements, and optimising the radiation dose on a moment-by-moment basis. This could further enhance the adaptive planning process, potentially making real-time adjustments even faster and more precise than a human could manage alone.

Beyond technological tweaks, MR-Linac innovation could also spur new treatment approaches. For example, clinicians are investigating ultra-high-dose radiation delivered in one or a few sessions (sometimes called “ablative” treatments) made possible by the precision of MR guidance. There is also interest in how MRI’s rich imaging could guide novel biological therapies – imaging not just anatomy but perhaps tumour function or metabolism during treatment to further tailor therapy.

As MR-Linac becomes more common, it will likely be a platform for many such innovations, from real-time biomarker monitoring to enhanced patient feedback (imagine a patient adjusting their breathing in response to visual cues from the machine to help guide the beam).

In summary, the future of radiation therapy with MR Linac looks bright and full of possibility. We anticipate smaller, smarter MR-Linacs that leverage AI and improved design, making this level of precision more available to patients everywhere. It’s a future where radiation treatments are quicker, smarter, and even more personalised, truly harnessing the “see as you treat” capability to its fullest potential.

Shaping the Next Generation of Cancer Treatment

The arrival of MR-Linac technology is a breakthrough in the history of radiation oncology. It does not often occur that one advancement can turn the playbook on curing cancer, but MRI-guided radiotherapy is doing exactly that. With the capability to see in real-time and be able to alter treatment, MR-Linac has added to the mix a level of control that has been on the horizon for a long time as an unattained dream.

This is revolutionizing the future of cancer treatment in many different ways. Patients can expect more efficient treatment with less collateral damage, revolutionising what was once a grueling cycle of radiation treatments to an acceptable, even convenient, procedure.

Oncologists gain an amazingly useful sidekick that enhances their abilities, technology that essentially provides them with “x-ray vision” (or rather MRI vision) during treatment, something their previous predecessors were able to dream of but not achieve. The technology is also creating partnerships between disciplines: radiologists, physicists, software engineers, and oncologists joining forces to push the boundaries of what is possible in treatment.

Enhancing the care that cancer patients receive is the central mission. We are already seeing trials and investigations reporting improved outcomes in diseases like prostate cancer using MRI-guided treatment, and this is most likely only the start. Short and sweet, MR-Linac is breaking new ground for cancer treatment with precision and personalisation at centre stage.

For more information about radiation, contact us, the radiation shielding experts at Raybloc. We are here to help you with any concerns you may have about radiation in any field, to ensure your safety and comprehension. Contact us today and let us assist you in understanding the intricacies of radiation exposure and safety.

FAQs

Which types of cancer benefit the most from MR-Linac technology?

MR-Linac is particularly valuable for cancers whose tumours change significantly during treatment, or are close to adjacent sensitive organs that you don’t wish to irradiate. High-risk-of-movement tumours, like lung tumours (which vary as the patient breathes), or prostate and bladder tumours (which can move as the bladder or bowel fills) – are perfect for MR-guided . The MR-Linac’s real-time tracking holds the radiation on such moving targets. Likewise, cancers in areas where precision is most important, such as pancreatic or liver tumours near sensitive structures, can greatly be helped by this technology.

Are there any side effects or risks associated with MR Linac radiotherapy?

MR-Linac radiotherapy itself doesn’t impose new side effects on top of those of regular radiation therapy – it’s actually designed to reduce side effects, not introduce them. However, patients may experience some of the normal side effects of radiotherapy, such as fatigue, skin reddening or stinging over the treated field (like mild sunburning), or mild changes in the treated organ (e.g., loose stools if the bowel borders the radiation field, or frequency if the prostate/bladder receives radiation). Initial trials, for instance, have shown lower rates of gastrointestinal side effects and better preservation of healthy tissue function with MRI-guided radiation compared to traditional methods.

How widely available is MR-Linac technology in hospitals and cancer centers?

MR-Linac technology is comparatively new, and currently it isn’t fitted in every hospital, far from it. It typically resides in large cancer centers, research facilities, or specialist clinics that have the budget to fit this cutting-edge equipment. During the early days of the technology, which clinically went live around 2017–2018, there were just a handful of MR-Linac machines worldwide, each at an elite oncology centre. In the UK, London’s The Royal Marsden Cancer Charity was the first to treat patients with MR-Linac, and others have since adopted it (some private cancer centres).The American Society for Radiation Oncology has endorsed MR-guided therapy in recent guidelines.

Can MR Linac treatments be combined with other cancer therapies?

Yes. MR Linac radiation therapy can be used in conjunction with other cancer treatments, as normal radiotherapy for patients. The MR-Linac is essentially a new technique of delivering radiation, therefore, any multi-modality treatment that includes radiation might possibly include MR-Linac delivered radiation. Patients may receive chemotherapy medication during the same time they are undergoing MR-Linac radiotherapy (this is standard in certain cancers like cervical or rectal cancer where chemo-radiation is standard).

About
Latest Posts

Follow me

Ishwari Patil

Radiation Shielding Specialist at Raybloc (X-Ray Protection) Ltd

With a unique blend of technical precision and creative thinking, I bring 4+ years of combined experience as an IT Automation Engineer and Marketing Professional to my current role at Raybloc. My journey began with a Bachelor's degree in Electronics and Telecommunication Engineering, where I developed a strong foundation in subjects like digital signal processing, circuit design, and embedded systems (areas that still influence how I approach complex projects today).

Building on this, I pursued a Master’s in Marketing from the University of Birmingham, UK (Russell Group institution). Here, I learned to back every campaign with rigorous research and thoughtful storytelling. This dual background allows me to bring a rare perspective to the table-one where analytical logic and imaginative flair work hand in hand.

What sets me apart as a marketer is exactly this fusion of engineering discipline and marketing insight. At Raybloc, I’ve found the perfect environment to apply both. From radiation shielding to innovations like the Sense-X® range, our products blend technology, healthcare, and design-areas I’m deeply passionate about. I love that my role enables me to continuously learn and contribute meaningfully to patient safety, NHS efficiency, and user-centred design.